Healthy Individuals That Control a Latent Infection with Mycobacterium tuberculosis Express High Levels of Th1 Cytokines and the IL-4 Antagonist IL-4δ2
- 1 June 2004
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 172 (11), 6938-6943
- https://doi.org/10.4049/jimmunol.172.11.6938
Abstract
The majority of healthy individuals exposed to Mycobacterium tuberculosis will not develop disease and identifying what constitutes “protective immunity” is one of the holy grails of M. tuberculosis immunology. It is known that IFN-γ is essential for protection, but it is also apparent that IFN-γ levels alone do not explain the immunity/susceptibility dichotomy. The controversy regarding correlates of immunity persists because identifying infected but healthy individuals (those who are immune) has been problematic. We have therefore used recognition of the M. tuberculosis virulence factor early secretory antigenic target 6 to identify healthy, but infected individuals from tuberculosis (TB)-endemic and nonendemic regions (Ethiopia and Denmark) and have compared signals for cytokines expressed directly ex vivo with the pattern found in TB patients. We find that TB patients are characterized by decreased levels of Th1 cytokines and increased levels of IL-10 compared with the healthy infected and noninfected community controls. Interestingly, the healthy infected subjects exhibited a selective increase of message for the IL-4 antagonist, IL-4δ2, compared with both TB patients or noninfected individuals. These data suggest that long-term control of M. tuberculosis infection is associated not just with elevated Th1 responses but also with inhibition of the Th2 response.Keywords
This publication has 29 references indexed in Scilit:
- Helicobacter pylori cagPathogenicity Island Is Associated with Reduced Expression of Interleukin-4 (IL-4) mRNA and Modulation of the IL-4δ2 mRNA Isoform in Human Gastric MucosaInfection and Immunity, 2003
- Dynamics of cytokine generation in patients with active pulmonary tuberculosisCurrent Opinion in Infectious Diseases, 2003
- Structural and Functional Properties of IL-4δ2, an Alternative Splice Variant of Human IL-4Journal of Proteome Research, 2003
- Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune ResponseThe Journal of Experimental Medicine, 2003
- Long‐Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from TuberculosisClinical Infectious Diseases, 2001
- Tuberculosis subunit vaccine development: on the role of interferon-γVaccine, 2001
- Antagonistic Effects of an Alternative Splice Variant of Human IL-4, IL-4δ2, on IL-4 Activities in Human Monocytes and B CellsCellular Immunology, 1999
- Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient PatientsScience, 1998
- Asthma in an AIDS patient with Norwegian scabies induced by bathing.Sexually Transmitted Infections, 1995
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993